As the battle against obesity takes on new dimensions, the company Orexigen™ Therapeutics, Inc. is developing two new diet pills, Empatic and Contrave, which are thought to be some of the more promising entries into the diet pill market. People who are overweight and those struggling to lose weight have many options but very few yield tangible results. Based on the theory that weight problems can be attributed to disrupted chemicals in the body instead of just a lack of physical exercise and poor diet, these diet pills seek to correct the problem.
Empatic and Contrave are new diet pills that are changing the way pharmaceuticals are used to promote weight loss.
Millions of dollars are spent annually in a bid to find the magic pill that will deliver what it promises – weight loss. Both Contrave and Empatic diet pills contain a combination of bupropion and zonisamide, which are both prescription drugs that have been found to promote weight loss effects. These ingredients constitute the concept of manipulating the brain’s ‘attitude’ towards food. It also aims to improve on the central nervous system when its functions are disrupted. This new age medical intervention puts aside the common theory of calories and lack of exercise as the root cause of weight gain. Instead, there is new focus on the brain that may be responsible for the eating habits of millions of overweight people around the world.
With the use of Contrave diet pills, the idea is to target the specific region of the brain that regulates how, when, what and why food is consumed. Similar to Contrave, Empatic diet pills are intended not only to kick-start weight loss, but to sustain long-term weight loss. With only a slight difference in the chemical composition of these diet pills, both Empatic and Contrave are directly associated with acting on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss.
Contrave and Empatic diet pill’s potent components perform well with neurotransmitters in the brain to encourage weight loss. The effectiveness and power of these diet pills are still undergoing clinical trials, but are showing promising results. There is sufficient evidence to support the theory that the drugs present in Empatic and Contrave diet pills are capable of reducing appetite and boosting energy expenditure while at the same time promoting weight loss. The combination of appetite suppression and a quickened metabolism rate are the basis of the pill’s weight loss approach, which has proven to be effective by other diet pills already sold, such as Phentramin-d and Phentermine.
The latest research that links a failure of the central nervous system to weight gain is bound to raise eyebrows and possibly change perceptions towards the issue of weight loss. Blaming the neurological element for overeating may make Empatic and Contrave bitter diet pills to swallow. After years of convincing people to cut their portions and exercise aggressively, breaking news revealing that these efforts are not actually the answer to weight loss will rock the weight loss industry to its knees. The latest solution to the obesity epidemic may lie in a set of diet pills that influence the way the central nervous system deals with food intake. Initial tests with Empatic and Contrave diet pills have been positive; significant weight loss and minimal adverse reactions have been reported.
Recent Comments